$9.82
$0.00 (0.00%)
End-of-day quote: 05/04/2024
NasdaqGS:LUNG
Pulmonx Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | ||
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$68.68M | $53.66M | $48.42M | $32.73M | |
| GM % | Gross Margin % |
|
73.90% | 74.29% | 73.59% | 64.77% | |
| OM | Operating Margin |
|
-90.19% | -109.27% | -97.70% | -98.77% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.60 | $-1.59 | $-1.35 | $-3.48 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | |
| Sha. | Shares |
|
38.52m | 37.56m | 36.93m | 35.69m | |
| OCF | Operating Cash Flow |
|
$-37.61M | $-45.08M | $-41.39M | $-30.63M | |
| FCF | Free Cash Flow |
|
$-32.10M | $-46.40M | $-45.06M | $-31.54M | |
| FCFS | Free Cash Flow Per Share |
|
$-1.01 | $-1.25 | $-1.25 | $-3.10 |
